27
Growth Score
pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1033105
Insulife develops Levellor™️, a spray-based insulin for needle-free delivery, aiming for FDA approval.
- Åge Nærdal: Chief Executive Officer & Founder
- Christian Theiste: Co-founder & Chief Operating Officer
About the Company
InsuLife is a company focused on developing a diabetes treatment. The company's developmental drug product, INS-2301, aims to be a skin-applied insulin, eliminating the need for needle injections. InsuLife's mission is to provide diabetics with a convenient, painless, and affordable insulin solution.
